Gabelli Securities »

Revance Therapeutics shares owned by Gabelli Securities

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Gabelli Securities from 13F filings

Historical chart of Gabelli Securities investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Gabelli Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Gabelli Securities

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.4M 840k 5.19

More positions owned by Gabelli Securities

Hess Corp Equity (HES)
Hashicorp Inc-cl A Equity (HCP)
Kellanova Equity (K)
Amedisys Equity (AMED)
Endeavor Group Hold-class A Equity (EDR)
Axonics Equity (AXNX)
Stericycle Equity (SRCL)
Juniper Networks Equity (JNPR)
Catalent Equity
Marathon Oil Corp Equity (MRO)
Albertsons Cos Inc - Class A Equity (ACI)
United States Steel Corp Equity (X)
Capri Holdings Equity (CPRI)
Squarespace Inc - Class A Equity (SQSP)
Perficient Equity (PRFT)

View all positions for Gabelli Securities

Top funds holding Revance Therapeutics

BlackRock
Vanguard Group
Franklin Resources
Fil
Alpine Associates Management
Alliancebernstein
Magnetar Financial
Tang Capital Management
State Street Corporation
Squarepoint Ops
Geode Capital Management
LMR Partners
D. E. Shaw & Co
Qube Research & Technologies
Omni Event Management

View all funds holding Revance Therapeutics